Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-25 · accession 0001567619-21-016409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-27 | 2021-08-25+ | MEDP | Medpace Investors, LLC | 10% | S - Sale | $180.52 | -8,088 | 6.04M | -0.1% | -$1.46M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-25 | S | D | 7,622 | $180.54 | 6,039,561 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $181.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2021-08-26 | S | D | 466 | $180.17 | 6,039,095 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.00 to $180.59. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |